Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza
NCT00833885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2011-04-22
Summary
With this study the investigators will try to assess the tolerability and measurability of the efficacy of non pharmaceutical measures to prevent seasonal influenza in individual households. Households with an identified index case of influenza will be randomised into one of three intervention arms: 1. group, where the household will receive general information about transmission of influenza virus and means to prevent it (Controls); 2. group, which will receive surgical masks and be asked to wear them whenever they are in close contact with the index case or other persons of the household that became ill during the observation period; 3. group, which will be given and asked to wear surgical masks as well as to execute intensified hand hygiene.
In addition to assessing the secondary attack rate as our primary outcome measure, the investigators will also try to evaluate compliance to those interventions by questionnaires.
Conditions
Interventions
- DEVICE
-
Masks
Wearing of surgical masks
- DEVICE
-
Masks & hand hygiene
Wearing of surgical masks and intensified hand washing
- OTHER
-
Control
General information about virus transmission in households and basic means to prevent it
Sponsors & Collaborators
-
Robert Koch Institut
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants
NCT06800885 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Household Influenza Transmission Study
NCT01251679 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
Evaluating Modes of Influenza Transmission Between Humans
NCT01150149 ·Status: WITHDRAWN ·Phase: NA
-
Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers
NCT04223544 ·Status: UNKNOWN
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners
NCT01207518 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above
NCT00345904 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults
NCT01302990 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
NCT01144299 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating the Effectiveness of a Seasonal Influenza Vaccination Promotion Campaign for Members of a Non-Profit, Community-Based Health Insurance Plan: 2018-2019
NCT03700281 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 ·Status: COMPLETED
-
Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects
NCT00481065 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
NCT00938392 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Modes of Influenza Transmission
NCT01710111 ·Status: COMPLETED ·Phase: NA
-
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults
NCT00706563 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting
NCT04568785 ·Status: COMPLETED ·Phase: NA
-
Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine
NCT01063088 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
NCT00476307 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
NCT00354016 ·Status: COMPLETED ·Phase: PHASE3